BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7885426)

  • 1. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol.
    el-Refaey H; Rajasekar D; Abdalla M; Calder L; Templeton A
    N Engl J Med; 1995 Apr; 332(15):983-7. PubMed ID: 7885426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical methods for first trimester abortion.
    Zhang J; Zhou K; Shan D; Luo X
    Cochrane Database Syst Rev; 2022 May; 5(5):CD002855. PubMed ID: 35608608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of misoprostol with and without laminaria tents for induction of second-trimester abortion.
    Jain JK; Mishell DR
    Am J Obstet Gynecol; 1996 Jul; 175(1):173-7. PubMed ID: 8694046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comparative Study to Evaluate the Efficacy of Vaginal vs Oral Prostaglandin E1 Analogue (Misoprostol) in Management of First Trimester Missed Abortion.
    Marwah S; Gupta S; Batra NP; Bhasin V; Sarna V; Kaur N
    J Clin Diagn Res; 2016 May; 10(5):QC14-8. PubMed ID: 27437309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised Control Study of Misoprostol and Mifepristone versus Misoprostol Alone in Second Trimester Termination of Pregnancy.
    Nayak AK; Mishra S; Mishra S; Patnaik R; Mohapatra I
    J Obstet Gynaecol India; 2023 Oct; 73(5):428-433. PubMed ID: 37916051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of combination RU 486-laminaria tents-misoprostol-peridural anesthesia in second and third trimester induced abortions].
    Hoffer MC; Charlier C; Giacalone PL; Zimbris L; Astruc M; Boulot P
    J Gynecol Obstet Biol Reprod (Paris); 1998 Jan; 27(1):83-6. PubMed ID: 9583050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abortion medical management between 14-16 weeks' amenorrhea after French legislation deadline extension.
    Carpentier H; Delotte J; Gauci PA
    J Gynecol Obstet Hum Reprod; 2024 Jan; 53(1):102705. PubMed ID: 38013013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-day versus two-day mifepristone-misoprostol interval prior to initiation of misoprostol during late second trimester medication abortion: A cohort study.
    Sium AF; Teklu H; Reeves M; Tolu LB; Prager S
    Contraception; 2024 Apr; 132():110356. PubMed ID: 38151223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxic shock associated with Clostridium sordellii and Clostridium perfringens after medical and spontaneous abortion.
    Cohen AL; Bhatnagar J; Reagan S; Zane SB; D'Angeli MA; Fischer M; Killgore G; Kwan-Gett TS; Blossom DB; Shieh WJ; Guarner J; Jernigan J; Duchin JS; Zaki SR; McDonald LC
    Obstet Gynecol; 2007 Nov; 110(5):1027-33. PubMed ID: 17978116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Medical strategy for abortions between 14 and 16 weeks of gestation].
    Bettahar K; Koch A; Deruelle P
    Gynecol Obstet Fertil Senol; 2022 Nov; 50(11):735-740. PubMed ID: 36183986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 24-Hour Compared With 12-Hour Mifepristone-Misoprostol Interval for Second-Trimester Abortion: A Randomized Controlled Trial.
    Meyer R; Toussia-Cohen S; Shats M; Segal O; Mohr-Sasson A; Peretz-Bookstein S; Amitai-Komem D; Sindel O; Levin G; Mashiach R; Blumenthal PD
    Obstet Gynecol; 2024 May; ():. PubMed ID: 38781593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study on the effectiveness of a combination regime (Mifepristone and Misoprostol) in comparison with Misoprostol for missed abortion.
    Gupta N; Tripathi R; Sharma S; Nigam A; Panesar S
    J Family Med Prim Care; 2023 Oct; 12(10):2423-2427. PubMed ID: 38074237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing the World Health Organization-versus China-recommended protocol for first-trimester medical abortion: a retrospective analysis.
    Ngo TD; Park MH; Xiao Y
    Int J Womens Health; 2012; 4():123-7. PubMed ID: 22505831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Termination of Pregnancy in First Trimester - Medical Option.
    Kumar S; Antony ZK; Kapur A; Togra M
    Med J Armed Forces India; 2005 Feb; 61(2):151-4. PubMed ID: 27407738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preabortion ultrasound - a patient perspective.
    Podolskyi V; Gemzell-Danielsson K; Marions L; Gomperts R
    Eur J Contracept Reprod Health Care; 2023 Oct; 28(5):268-273. PubMed ID: 37698511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of misoprostol with and without evening primrose (
    Mahmoodinasab M; Loripoor M; Vazirinejad R; Aminzadeh F
    Avicenna J Phytomed; 2023; 13(5):454-462. PubMed ID: 38089421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. United Kingdom Data Deficiencies Influencing U.S. FDA Decisions.
    Skop I; Miller C; Duffy K
    Issues Law Med; 2024; 39(1):32-49. PubMed ID: 38771713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progesterone after mifepristone: A pilot prospective single arm clinical trial for women who have changed their mind after commencing medical abortion.
    Turner JV; Garratt D; McLindon LA; Barwick A; Spark MJ
    J Obstet Gynaecol Res; 2024 Feb; 50(2):182-189. PubMed ID: 37944947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using a Call Center to Reduce Harm From Self-Administration of Reproductive Health Medicines in Bangladesh: Interrupted Time-Series.
    Keenan K; Footman K; Sadekin M; Reiss K; Yasmin R; Franklin H; Church K
    JMIR Public Health Surveill; 2019 Aug; 5(3):e12233. PubMed ID: 31418425
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.